Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04800289
What this trial is testing

Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist

Who this might be right for
Psoriatic Arthritis
Centre Hospitalier le Mans 600
Testing effectiveness (Phase 2)Study completedNCT04612699
What this trial is testing

Jaktinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 123
Not applicableEnded earlyNCT01088698
What this trial is testing

Golimumab Plus UVB-311nm in Psoriasis

Who this might be right for
Psoriasis
Medical University of Graz 20
Not applicableStudy completedNCT05811234
What this trial is testing

Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 291
Early research (Phase 1)Ended earlyNCT06005792
What this trial is testing

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Xencor, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00809614
What this trial is testing

Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT06586112
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 912
Post-approval studies (Phase 4)UnknownNCT02132234
What this trial is testing

Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis+1 more
Jagiellonian University 100
Large-scale testing (Phase 3)Study completedNCT01646177
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,346
Large-scale testing (Phase 3)Study completedNCT00715975
What this trial is testing

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Who this might be right for
Psoriasis
Azidus Brasil 140
Not applicableStudy completedNCT02954081
What this trial is testing

APremilast After FumaRic Acid Ester Treatment

Who this might be right for
Psoriasis
Amgen 687
Not applicableActive Not RecruitingNCT07730619
What this trial is testing

To Explore the Influencing Factors and Solutions for Patients With Plaque Psoriasis Undergoing Relapse

Who this might be right for
Plaque PsoriasisBiologic AgentsRelapse+1 more
First Affiliated Hospital Xi'an Jiaotong University 140
Testing effectiveness (Phase 2)Ended earlyNCT03339999
What this trial is testing

AGN-242428 in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Vitae Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158268
What this trial is testing

HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 220
Not applicableNot Yet RecruitingNCT07336641
What this trial is testing

LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice

Who this might be right for
PsoriasisAtopic DermatitisVitiligo+2 more
Fondazione ISIDE 20,000
Not applicableLooking for participantsNCT05111210
What this trial is testing

Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

Who this might be right for
Psoriasis
Institut Pasteur 90
Not applicableUnknownNCT02813720
What this trial is testing

Distal Erosions and Nail Psoriasis

Who this might be right for
Psoriatic Arthritis
Hospices Civils de Lyon 104
Large-scale testing (Phase 3)UnknownNCT06299982
What this trial is testing

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

Who this might be right for
Plaque Psoriasis Patients
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Not applicableStudy completedNCT03173144
What this trial is testing

Chronic Inflammatory Disease, Lifestyle and Treatment Response

Who this might be right for
Autoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+7 more
University of Southern Denmark 233
Large-scale testing (Phase 3)Study completedNCT01206660
What this trial is testing

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 120
Next Page